Objective This study evaluates the difference between winter influenza and summer influenza in Okinawa.
Introduction
The seasonal patterns of human influenza in temperate regions have been well documented; however, the seasonal patterns in tropical and subtropical areas are not as simple or as well pronounced as those in temperate regions around the world. It has been demonstrated that in subtropical areas such as Taiwan, Hong Kong, and Singapore, influenza epidemics are observed throughout the year (1) . The Okinawan islands are located in the southernmost part of Japan (latitude 26°N), where the climate is also subtropical.
In Okinawa, several episodes of influenza epidemics occur during the summer season (2) (3) (4) (5) . This report describes the results of an eight-year surveillance of influenza incidence in the Naha region of Okinawa Island. In addition, to further understand influenza epidemics during the summer in Okinawa, we compared the types of viruses obtained in the winter season with the types of viruses obtained in the summer seasons. Furthermore, full genome sequences of representative human influenza A and influenza B were evaluated to demonstrate the differences between viruses with the same antigenic determinants.
Materials and Methods

Study population and influenza antigen tests
Patients with influenza-like symptoms visiting one of the four general hospitals within the cities of Naha and Urasoe, Okinawa, between January 2007 and December 2014 were included in this study. Intranasal or throat swab specimens were obtained when influenza was clinically suspected by physicians. Rapid antigen tests (RATs) using the nasal or throat swab samples were then performed to diagnose influenza A or B infection. This diagnostic procedure is part of conventional clinical practice. The RAT results were anonymously collected from the hospitals by the Clinical Laboratory Center of the Medical Association of Naha City, Okinawa. The investigation period included the H1N1 2009 pandemic (H1N1pdm) in Okinawa.
Virus isolation
Nasopharyngeal specimens from influenza patients were collected at sentinel medical facilities before the initiation of influenza therapy. The samples were kept at 4 at the medical facilities and transferred to the microbiology division of the Okinawa Prefectural Institute of Health and Environment for influenza virus isolation and growth. After viral culture, supernatants (200 μL) of nasopharyngeal swabs were inoculated into Madin-Darby canine kidney (MDCK) cells, with 1 mL of maintenance medium, containing trypsin at a concentration of 5.0 μg/mL, per well in 24-well plates. The plates were incubated at 35 in a 5% CO2 atmosphere for 1 week to assess the cytopathic effects. All of the isolates were typed and subtyped by the hemagglutination inhibition assay.
Genomic analysis
RNA extraction
The analyzed samples were unlinked and anonymous in the Osaka Prefectural Institute of Public Health. This study was approved by the ethics review committee of both the Osaka Prefectural Institute of Public Health and Osaka University. Viruses were propagated in MDCK cells. The supernatants were suspended in TRIzol LS Reagent (Life Technologies, Carlsbad, CA, USA) for 60 minutes. Total RNA was extracted using a PureLink™ RNA Mini Kit (Life Technologies) in accordance with the manufacturer's instructions. Contaminating DNA was eliminated with DNAase I (Life Technologies).
One-step reverse transcription-PCR (RT-PCR)
Total RNA was subjected to One-step RT-PCR using SuperScript III/Platinum Taq HiFi One-step RT-PCR Kit (Life Technologies) to detect the receptor-binding site within the hemagglutinin (HA) molecule. The primers used were as follows: forward primer, 59-416TTGAAAGGTTTGAGATAT TC435-39; reverse primer, 59-784CTAGTGTCCAGTAATAG TTC765-39. RNA was extracted using a QIAamp viral RNA Mini kit (QIAGEN Inc., Valencia, CA, USA). A 140-μL volume of virus suspension from the infected culture or embryonated egg yielded a volume of 60 μL of extracted RNA.
Genomic shotgun sequencing and data analysis Extracted RNA from the supernatant of MDCK culture was subjected to direct metagenomics shotgun sequencing. The RNA samples were reverse transcribed with Superscript III (Life Technologies) and converted to double-stranded DNA using the Klenow Fragment (New England Biolabs Inc., Ipswich, MA, USA). The resulting DNA was treated with Nextra XT DNA Library Prep Kit (Illumina, San Diego, CA, USA). Genomic shotgun sequencing was performed on MiSeq (Illumina). The sequence reads assigned to influenza viruses were collected and assembled using the CLC genomics work bench software program (QIAGEN Inc.).
Review of literature
We reviewed articles concerning summer influenza through MEDLINE (key words: influenza and summer). Articles not listed in the MEDLINE and those written in languages other than English were excluded.
Results
The Based on the evidence demonstrated in Table 1 , the virus type in the winter was frequently similar to the previous summer pattern. In addition, influenza viruses cultured during the winter and summer of the same year had antigenic differences, except in 2012. Furthermore, influenza B virus was observed consistently and with a higher incidence in the summer seasons, except for the summer of 2009, where A/H1N1pdm dominated. Interestingly, in 2012, the A/H3N2 virus demonstrated equal incidence during winter and summer. (Fig. 2) This study utilized 28 human A/H3N2 influenza virus isolates. A genomic analysis of the samples derived from the same time period revealed that influenza outbreaks may not contain closely related viruses, in Okinawa. However, A/H3N2 (Jun 17/2008) was more closely related to A/H3N2 (Jan 23/2009) than any other sequence. Additionally, A/H3N2 (Aug 20/2012) more closely resembled A/H3N2 (Jan 10/2013) than any other sequence. Taken together, these data suggest that even though the antigenic type was the same, the genomic patterns of summer viruses diverge from previous winter viruses and more closely resemble the viruses detected during the following winter seasons. (Table 2) There are many reports regarding summer influenza . Recently, there have been several reports concerning summer influenza from the southern parts of China in multiple climatic environments (7, 8, 10-12, 14-17, 20, 22-24, 26) . Summer influenza has also been reported from other subtropical areas such as, Mexico (9), Pakistan (21), Taiwan (6, 25) and Vietnam (32) . Epidemics of summer influenza in Japan have been reported in Okinawa (2-5), Hokkaido (31) , and Nara (33) . In older reports, influenza epidemics in summer were observed primarily as a result of travel (29, (37) (38) (39) or as small, contained outbreaks (30, (33) (34) (35) 40) . Furthermore, in recent articles, it has been demonstrated that summer influenza can be a frequent cause of acute respiratory infections in children and adults (4, 12-16, 18, 21-24) .
Genomic analysis
Review of the literature
Discussion
In subtropical areas, it is well-known that influenza pandemics frequently occur in the summer season. In addition, there are several reports concerning summer influenza from the southern parts of China. However, the mechanism behind summer influenza epidemics has not been clarified. As demonstrated in this study, summer epidemics of influenza were frequently observed in the subtropical area of Okinawa, Japan. Furthermore, it has been demonstrated that summer influenza was one of the main causes of acute respiratory infections in children and adults in summer seasons (4, 12-16, 18, 21-24) , especially in subtropical areas. Influenza B viruses have been proven to play an important role in summer epidemics and therefore more research should be devoted to determining the molecular correlates or environmental factors causing summer respiratory infections.
Our data also show that the types of influenza viruses obtained in winter are different from those obtained during the summer. A genomic analysis showed that the H3N2 viruses obtained in winter season were genetically different from those cultured in summer. The observed genomic patterns further suggest that summer viruses diverge from the previous winter viruses and more closely resemble the viruses detected in the following winter seasons, providing further proof that subtropical areas of Asia are an important breeding ground for emerging influenza strains.
The impact of the H1N1 2009 pandemic on subtropical and tropical regions is of interest. In the summer of 2009, a new influenza virus produced a significant pandemic in Okinawa. This evidence supports the idea when new and more virulent viruses emerge, significant epidemics can result, regardless of the season.
The data shown in Table 2 indicate that summer influenza has been reported quite frequently recently, especially in subtropical cities. In previous reports, epidemics were found to be related to travel (29, (37) (38) (39) or occurred in restricted institutions (30, 31, 34, 35, 40) . However, recently, epidemics of the H5N1 avian influenza (13), H7N9 avian influenza (17) , and A/H1N1pdm (4, 9, 19) have been reported. Very recently, Hsieh et al. reported on virus types circulating in Taiwan (6) . In addition, Zheng et al. reported virus types circulating in Jingzhou, China (7) . Surprisingly, the virus types detected in Okinawa are very closely related to those detected in Taiwan (6) and Hong Kong (11) but not in Jingzhou, China (7) or in Pakistan (21) , suggesting that the viruses detected in Okinawa might be derived from Taiwan or Hong Kong, or vice-versa.
In conclusion, antigenic and phylogenetic data analyses revealed that influenza viruses consistently co-circulate in Okinawa, causing both summer and winter epidemics. More research is needed to determine the molecular components that cause virulence on a pandemic scale. Our analysis showed that new phylogenetic lineages and antigenic variants emerging in summer were likely to be the progenitors of the epidemic strains during the following traditional winter flu season. Okinawan flu samples might provide important clues for predicting which strains of influenza virus will spread globally.
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